StockData
Abpro Holdings, Inc. logo

Abpro Holdings, Inc. (ABPO) stock

ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.41+0.00 (+0.11%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Abpro operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Abpro's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.59M. For fiscal 2025 it was -$6.01M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.01M–
FY2024Dec 31, 2024-$9.03M–
FY2023Dec 31, 2023-$7.40M–
FY2022Dec 31, 2022-$1.18M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.05M–
Q1 FY2026Mar 31, 2026-$2.08M–
Q4 FY2025Dec 31, 2025-$620.00K–
Q3 FY2025Sep 30, 2025-$2.83M–
Q2 FY2025Jun 30, 2025-$1.05M–
Q1 FY2025Mar 31, 2025-$1.50M–
Q2 FY2024Jun 30, 2024-$1.37M–
Q1 FY2024Mar 31, 2024-$2.85M–
Q4 FY2023Dec 31, 2023-$5.90M–
Q3 FY2023Sep 30, 2023-$1.28M–
Q2 FY2023Jun 30, 2023-$129.78K–
Q1 FY2023Mar 31, 2023-$97.22K–
Q4 FY2022Dec 31, 2022-$128.10K–
Q3 FY2022Sep 30, 2022-$94.00K–
Q2 FY2022Jun 30, 2022-$35.54K–
Q1 FY2022Mar 31, 2022-$927.32K–

More Abpro figures

See a number that looks wrong?